John W. Walsh Alpha-1 Home Infusion Act of 2023
Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 30, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
John W. Walsh Alpha-1 Home Infusion Act of 2023
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Cosponsors 59
Members who signed on, in the order they did. Signatures ran from Jun 30, 2023 to Oct 1, 2024; 8 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-FL | Bill Posey | Original | Jun 30, 2023 |
| D-NY | Brian Higgins | Original | Jun 30, 2023 |
| D-ME | Chellie Pingree | Original | Jun 30, 2023 |
| D-FL | Debbie Wasserman Schultz | Original | Jun 30, 2023 |
| D-VA | Gerald E. Connolly | Original | Jun 30, 2023 |
| D-CA | Jimmy Panetta | Original | Jun 30, 2023 |
| D-NY | Paul Tonko | Original | Jun 30, 2023 |
| D-MA | William R. Keating | Original | Jun 30, 2023 |
| D-NC | Donald G. Davis | Jul 14, 2023 | |
| D-NC | Deborah K. Ross | Jul 27, 2023 | |
| R-NE | Don Bacon | Aug 11, 2023 | |
| R-UT | Burgess Owens | Sep 12, 2023 | |
| R-NY | Anthony D'Esposito | Sep 14, 2023 | |
| D-PA | Madeleine Dean | Sep 18, 2023 | |
| R-NY | Nicholas A. Langworthy | Sep 18, 2023 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Jun 30, 2023Referred Jun 30, 2023 |
| Health Subcommittee | Referred Jul 7, 2023 | |
| House | Ways and Means Committee | Jun 30, 2023Referred Jun 30, 2023 |
| Health Subcommittee | Referred Dec 17, 2024 |
Actions 4
Everything that happened, newest first.
- Dec 17, 2024Referred to the Subcommittee on Health.
- Jul 7, 2023Referred to the Subcommittee on Health.
- Jun 30, 2023Introduced in House
- Jun 30, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 114, June 30, 2023, page H3162.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.
- Short Title(s) as Introduced
- John W. Walsh Alpha-1 Home Infusion Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jun 30, 2023Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.